2019
DOI: 10.4103/ijd.ijd_229_17
|View full text |Cite
|
Sign up to set email alerts
|

Squamous cell carcinoma versus malignant proliferating trichilemmal tumor: A histopathological dilemma with review of literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
11
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 5 publications
0
11
0
Order By: Relevance
“…Interestingly, in human medicine, variants of tumors arising from squamous epithelium or resembling SCC have been described in the skull. They include adenosquamous carcinoma and benign and malignant proliferating trichilemmal tumors in addition to SCC [7,13,28,29]. Their differentiation is based on careful microscopic analysis and is sometimes also supported by immunohistochemistry [28].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Interestingly, in human medicine, variants of tumors arising from squamous epithelium or resembling SCC have been described in the skull. They include adenosquamous carcinoma and benign and malignant proliferating trichilemmal tumors in addition to SCC [7,13,28,29]. Their differentiation is based on careful microscopic analysis and is sometimes also supported by immunohistochemistry [28].…”
Section: Discussionmentioning
confidence: 99%
“…They include adenosquamous carcinoma and benign and malignant proliferating trichilemmal tumors in addition to SCC [7,13,28,29]. Their differentiation is based on careful microscopic analysis and is sometimes also supported by immunohistochemistry [28].…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, the absence of an overlying precursor epidermal lesion (e.g. an actinic keratosis) favors a diagnosis of MPTT over squamous cell carcinoma in situ [ 7 ].…”
Section: Discussionmentioning
confidence: 99%
“…IHC has been proposed to be of utility in distinguishing MPTTs and squamous cell carcinomas [ 7 ]. However, based on our literature review, we suggest IHC be of limited value, as no IHC marker is consistently and specifically expressed to be reliably used in diagnosing MPTT (Table 1 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation